In this study, we investigate the expression of CD70 using immunohistochemistry (IHC), flow cytometry (FC), and dual immunofluorescence (IF), in bone marrow samples from treatment-naïve and relapsed AML patients after HMA. The gene discussed is CD70; the disease is acute myeloid leukemia.